Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 16926 - 16950 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cidofovir	Approved Investigational	VIPR1	7433	upregulated	cidofovir results in increased expression of VIPR1 mRNA	3p22.1	A20427
Cidofovir	Approved Investigational	VTCN1	79679	upregulated	cidofovir results in increased expression of VTCN1 mRNA	1p13.1-p12	A20427
Cidofovir	Approved Investigational	WARS	7453	upregulated	cidofovir results in increased expression of WARS mRNA	14q32.2	A20427
Cidofovir	Approved Investigational	WWC2	80014	downregulated	cidofovir results in decreased expression of WWC2 mRNA	4q35.1	A20427
Cidofovir	Approved Investigational	XBP1	7494	upregulated	cidofovir results in increased expression of XBP1 mRNA	22q12.1	A20427
Cidofovir	Approved Investigational	XPC	7508	upregulated	cidofovir results in increased expression of XPC mRNA	3p25.1	A20427
Cidofovir	Approved Investigational	YTHDC2	64848	downregulated	cidofovir results in decreased expression of YTHDC2 mRNA	5q22.2	A20427
Cidofovir	Approved Investigational	ZMAT3	64393	upregulated	cidofovir results in increased expression of ZMAT3 mRNA	3q26.32	A20427
Cidofovir	Approved Investigational	ZNF561	93134	downregulated	cidofovir results in decreased expression of ZNF561 mRNA	19p13.2	A20427
Ciglitazone	Experimental	ABHD3	171586	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ABHD3 mRNA	18q11.2	A21647
Ciglitazone	Experimental	ABHD3	171586	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of ABHD3 mRNA	18q11.2	A21647
Ciglitazone	Experimental	ACAA1	30	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of ACAA1 mRNA	3p22.2	A21647
Ciglitazone	Experimental	ACAA2	10449	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ACAA2 mRNA	18q21.1	A21647
Ciglitazone	Experimental	ACADM	34	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ACADM mRNA	1p31.1	A21647
Ciglitazone	Experimental	ACADM	34	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of ACADM mRNA	1p31.1	A21647
Ciglitazone	Experimental	ACADVL	37	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ACADVL mRNA	17p13.1	A21647
Ciglitazone	Experimental	ACSL1	2180	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of ACSL1 mRNA	4q35.1	A21647
Ciglitazone	Experimental	ACSM3	6296	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ACSM3 mRNA	16p12.3	A21647
Ciglitazone	Experimental	AKAP2	11217	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of AKAP2 mRNA	9q31.3	A21647
Ciglitazone	Experimental	AKR1C1	1645	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of AKR1C1 mRNA	10p15.1	A21647
Ciglitazone	Experimental	AKR1C1	1645	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of AKR1C1 mRNA	10p15.1	A21647
Ciglitazone	Experimental	AKR1C2	1646	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of AKR1C2 mRNA	10p15.1	A21647
Ciglitazone	Experimental	AKR1C2	1646	upregulated	[ciglitazone binds to PPARG protein] which results in increased expression of AKR1C2 mRNA	10p15.1	A21647
Ciglitazone	Experimental	ANG	283	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ANG mRNA	14q11.2	A21647
Ciglitazone	Experimental	ANGPTL4	51129	upregulated	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ANGPTL4 mRNA	19p13.2	A21647

Displaying entries 16926 - 16950 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability